Jason Drew Smith, General Counsel at UroGen Pharma Ltd. (URGN), sold 1,519 shares at $42.54 ($65K) on 2026-09-08, disclosed to the SEC on 2026-09-09.
Seasonal sale ($65k) by General Counsel — this insider has traded URGN in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| URGN | SELL | 2025-07-30 | $288K | — | Filing → |
| URGN | SELL | 2025-02-04 | $82K | — | Filing → |
| URGN | SELL | 2024-09-12 | $20K | — | Filing → |